Afucosylated C9 Antibody Boosts Anti-Tumor Cytotoxicity Against Oncofetal Chondroitin Sulfate
Fc afucosylation significantly enhances the anti-tumor cytotoxicity of the C9 monoclonal antibody targeting cancer-associated oncofetal chondroitin sulfate in melanoma models.

